Ono Pharmaceutical Co Ltd 2022 Sustainability Report
The report describes the company's FY2021 progress toward decarbonization, including 23.6 kt-CO2 of market-basis Scope 1 and 2 emissions and a 17.0% renewable energy utilization rate. Water intake decreased to 219.4 thousand m3, while industrial waste volume was 479.1 tons and the final landfill rate was 0.04%. The report also includes group governance, human rights, employee development, SDG contributions, TCFD analysis, and independently assured sustainability data.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2022
Type: Sustainability Report
Pages: 188
Back to company
Ono Pharmaceutical Co Ltd
Sustainability Report
The report describes the company's FY2021 progress toward decarbonization, including 23.6 kt-CO2 of market-basis Scope 1 and 2 emissions and a 17.0% renewable energy utilization rate. Water intake decreased to 219.4 thousand m3, while industrial waste volume was 479.1 tons and the final landfill rate was 0.04%. The report also includes group governance, human rights, employee development, SDG contributions, TCFD analysis, and independently assured sustainability data.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2021
Published
Oct 1, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees